期刊文献+

酰基化ghrelin通过PI3K/Akt通路抑制高糖诱导的内皮细胞凋亡 被引量:4

Acylated ghrelin inhibits high glucose-induced apoptosis in endothelial cells through PI3K/AKT pathway
原文传递
导出
摘要 目的研究酰基化ghrelin在高糖诱导的血管内皮细胞凋亡中的作用。方法通过Western-Blot、分光光度比色法分别检测Akt(Ser 473)磷酸化水平及caspase-3活性。结果 (1)不同浓度ghrelin(10^(-6)mol/L、10^(-7)mol/L)作用内皮细胞30min对Akt磷酸化作用的差异有统计学意义(P<0.05),而ghrelin(10^(-7)mol/L、10^(-8)mol/L、10^(-9)mol/L)浓度之间没有统计学差异(P>0.05),暴露于酰基化ghrelin(10^(-7)mol/L)中细胞内Akt迅速磷酸化,在30 min达高峰。(2)PI3K抑制剂LY294002可以减弱ghrelin对高糖(33.3mmol/L)环境下caspase-3活化的抑制作用。结论酰基化ghrelin通过PI3K/Akt通路抑制高糖诱导的内皮细胞凋亡,在糖尿病血管并发症的防治中可能有一定的意义。 Objective To investigate the role of acylated ghrelin in high glucose-induced apoptosis of ECV- 304 cells. Methods Western-blot and colorimetric assay were used. Results (1) Exposure of endothelial cells to acylated ghrelin (10^-7 M)rapidly caused activation of Akt, and the effect reached the peak at 30 min. A significant di(ference was observed in Akt phosphorylation level between 10^6 M and 10^-7 M ghrelin (P〈0. 05), but there were no significant differences among different concentrations of acylated ghrelin (10^-7 M, 10^-8 M, 10^-9 M) (P〉0. 05). (2) The inhibition effect of acylated ghrelin on caspase-3 activition under high glucose (33. 3 mM) was blocked by PI3K inhibitor (HG+G: 1. 051 ±0. 014 HG+ G+Inhib: 1. 196±0. 041,P〈0. 05). Conclusions Aeylated ghrelin inhibits high glucose-induced apoptosis in endothelial cells through PI3K/Akt pathway, and the peptide may have potential in preventing diabetic complications.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第3期225-227,共3页 Chinese Journal of Diabetes
关键词 GHRELIN 内皮细胞 高糖 凋亡 Ghrelin Endothelial cells High glucose Apoptosis
  • 相关文献

参考文献5

  • 1Kojima M,Hosoda H,Date Y,et al.Ghrelin is a growth-hormone-releasing acylated peptide from stomach.Nature,1999,402:656-660.
  • 2Gnanapavan S,Kola B,Bustin SA,et al.The tissue distribution of the mRNA of ghrelin and subtypes of its receptor,GHS-R,in humans.J Clin Endocrinol Metab,2002,87:2988.
  • 3高燕明,卢桂芝,董爱梅,陈宇,杨建梅,蔡大勇,庞永正,唐朝枢.2型糖尿病和糖调节受损患者在葡萄糖负荷时血浆Ghrelin水平的变化及其与胰岛素的关系[J].中华糖尿病杂志(1006-6187),2004,12(5):352-355. 被引量:2
  • 4Konturek PC,Brzozowski T,Walter B,et al.Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide.EurJ Pharmacol,2006,536:171-181.
  • 5Li WG,Gavrila D,Liu X,et al.Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells.Circulation,2004,109:2221-2228.

二级参考文献9

  • 1Cappiello Ⅴ, Ronchi C, Morpurgo PS, et al. Circulating Ghrelin levels in basal conditions and during glucose to1erance test in acromegalic patients. Eur J Endocrinol, 2002,147:189-194.
  • 2Shiiya T, Nakazato M, Mizuta M,et al. Plasma Ghrelin levels in lean and obese humans and the effect of glucose on Ghrelin secretion. J Clin Endocrinol Metab, 2002,87 : 240-244.
  • 3Haqq AM, Farooqi IS, O'Rahilly S, et al. Serum Ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in prader-willi syndrome. J Clin Endocrinol Metab, 2003, 88: 174-178
  • 4Date Y, Nakazato M, Hashiguchi S,et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes, 2002,51:124-129.
  • 5Egido EM, Rodriguez-Gallardo J, Silvestre RA, et al. Inhibitory effect of Ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol, 2002,146: 241-244.
  • 6Anderwald C, Brabant G, Bernroider E,et al. Insulin-dependent modulation of plasma Ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes, 2003,52:1792-1798.
  • 7Schofl C, Horn R, Schill T,et al. Circulating Ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab, 2002,87 : 4607-4610.
  • 8Makino Y, Hosoda H, Shibata K, et al. Alteration of plasma Ghrelin levels associated with the blood pressure in pregnancy.Hypertension, 2002,39: 781-784.
  • 9Poykko S, Ukkola O, Kauma H, et la. Ghrelin Arg 51 Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia, 2003,46:455-458.

共引文献1

同被引文献43

  • 1王春花,刘克明,张明月,刘玉清.SOD基因表达与衰老的相关性[J].中国公共卫生,2004,20(8):953-954. 被引量:16
  • 2孟东,陈樱,刘德敏,卫丽君,马金荣,张怡,于德民.高糖对人脐静脉内皮细胞凋亡及bcl-x、bax和eNOS表达的影响[J].天津医药,2005,33(6):335-337. 被引量:12
  • 3林少达,陈小华.Ghrelin对心血管系统作用的研究进展[J].心血管康复医学杂志,2006,15(2):191-193. 被引量:3
  • 4耿静,宋敏,葛志明.糖尿病心肌病的研究进展[J].中国心血管病研究,2007,5(6):468-471. 被引量:23
  • 5Kojima M, Hosoda H, Date Y, et al. Ghrelin is a novel growth hormone releasing acylated peptide from stomach [ J ]. Nature, 1999 ; 402 ( 6762 ) : 656-60.
  • 6Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue bidning sites in peripheral human tissues [ J]. J Clin Endocrinol Met, 2000;85 (10) :3803-7.
  • 7Iglesiasa M J, Pineiroa R, Blanco M, et al. Growth hormone releasing peptide(ghrelin) is synthesized and secreted by cardiomyocytes [ J]. Cardiovasc Res,2004 ;62 (3) :481-8.
  • 8Kim SW, Her S J, Park S J, et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells [J]. Bone,2005 ;37(3) :359-69.
  • 9Zhang Y, Ying B, Shi L, et al. Ghrelin inhibit cell apoptosis in pancreatic beta cell line HIT-T15 via mitogen-activated protein kinase/phosphoinositide 3-kinase pathways [J]. Toxicology, 2007 ; 237 (1-3 ) : 194- 202.
  • 10Kim MG, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes, Mol[ J ]. Endocrinology, 2004 ; 18 (9) :2291-301.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部